I’ve spent the last several years doing a very specific, very unglamorous job: cleaning up other people’s mess. Vascular occlusions at 11pm. Necrosis nobody wants to photograph. Panicked voice notes from practitioners who did a foundation course, got their certificate, and have never once been shown what a compromised vessel actually looks like under their own hands. I’ve now trained hundreds of practitioners up and down the country in managing these situations themselves, and if there’s one thing that unites almost every single one of them before they walk into my room, it’s this: nobody ever properly taught them what to do. That’s not a training gap. That’s an industry choice.
Let’s start with the numbers, because I’d rather you didn’t take my word for it. In 2023, an estimated 7.7 million people in the UK had a cosmetic or aesthetic treatment, in a non-surgical sector worth roughly £10.1 billion a year, with something like 900,000 botulinum toxin treatments delivered annually and procedure numbers having risen 102% in a single year not long before that.1 That is an enormous amount of needles going into an enormous number of faces. And yet, as the House of Commons Library’s own briefing on this sector states plainly, “there is no specific requirement for practitioners to undertake education or training before delivering non-surgical cosmetic procedures”.2 One government minister has called it, accurately, a “Wild West.” An MP put it even more bluntly in a recent Commons debate, describing how you could complete roughly ten hours of coursework and two days in person and then call yourself “qualified” to inject toxin or dissolve fat.1
So we have a multi-billion-pound medical intervention sector with essentially no mandatory floor for training, and a workforce entering it faster than anyone can regulate. What could possibly go wrong? Rhetorical question, obviously.
In 2023 alone, over 3,000 complications were reported to the Save Face register.3 A 2025 ITV investigation found that half of women surveyed needed medical assistance after a non-surgical procedure, and 15% needed emergency support.1 We had a UK-wide botulism scare linked to counterfeit toxin in summer 2025, with 38 confirmed cases in six weeks and 28 people affected in the north-east in a single month. NHS Scotland has calculated the average cost of correcting a botched procedure at over £9,000, and correcting treatments done abroad costs the NHS an estimated £1.7 million a year.1 Meanwhile, systematic review data on vascular occlusion following filler puts overall incidence below 1%, with the most feared complication, filler-induced blindness, carrying a documented rate of permanent vision loss in 68% of the 511 reported global cases, and a treatment window for the retina measured not in hours but in 12 to 15 minutes.4 That is roughly the length of time it takes most people to find a parking space outside their own clinic.
Here’s my genuinely controversial bit, the part I’d say to your face at a conference bar rather than just in print: the industry doesn’t actually have a training problem. It has a business model problem, and the two get conveniently confused.
Foundation training in this sector spends almost no time on complications, because complications don’t sell foundation courses; confidence does. Then, further down the funnel, a certain flavour of “advanced” complications training has worked out something rather clever: teach practitioners just enough to be terrified, not quite enough to be competent, and then offer them the safety net. For a monthly fee, naturally. You will be trained to recognise a problem, feel the cold sweat of liability, and then dial a number and hand the patient (and the fee) to someone else. It is a beautifully self-sustaining ecosystem. Fear is retained as a customer. I don’t think this is always a conscious, moustache-twirling strategy. I think plenty of well-meaning trainers have built it without noticing what it does. But intent doesn’t change the outcome, and the outcome is a generation of practitioners who can spot a problem but have been quietly, structurally discouraged from ever being trusted to finish treating it.
I think that’s indefensible, and I think it’s worth saying so plainly in a journal read by the people doing the treating. You are not children. You do not need a permanent chaperone. You need proper anatomy, proper protocols, hands-on practice with real complication scenarios, and someone honest enough to tell you when a case genuinely is beyond you, which is rare, not routine. My own course exists because I got tired of watching capable, conscientious practitioners taught to panic instead of act, and I’ll say this once and move on: it’s built entirely around competent independent management, not a referral pipeline back to me. If a course teaches you to recognise danger and then makes escalation the punchline, ask yourself who that structure actually serves.
None of this lets foundation training off the hook, and I don’t want anyone reading this to think the “advanced” tier is the whole story. The real root cause sits earlier: a Level 7 qualification and its equivalents can get someone injecting with barely a passing acquaintance with vascular anatomy under duress, let alone a rehearsed, muscle-memory response to an evolving occlusion.
The Joint Council for Cosmetic Practitioners has a competency framework; it is voluntary. Save Face and the JCCP registers exist; joining them is voluntary. The government’s own response to the Health and Care Act 2022 licensing powers, published in August 2025, finally proposes a tiered green/amber/red system for procedures based on risk, with high-risk work restricted to regulated healthcare professionals under CQC oversight.2 It is a good step. It is also years overdue, and it still says nothing concrete yet about mandating complications competency specifically, rather than just gatekeeping who’s allowed to hold the needle.
So here is where I land: regulation will eventually turn up to this party, fashionably late, and take some credit for a fix the industry should have built itself a decade ago. In the meantime, complications management cannot keep being the module nobody teaches properly, sandwiched between a lunch break and a certificate ceremony. It has to become foundational, not an upsell, and it has to actually produce practitioners who can act decisively, correctly, and without needing to escalate to someone with a WhatsApp number and an invoice ready to go. Ninety percent of vascular complications resolve fully when recognised and treated promptly.4
Promptly means the person already holding the needle, not the one at the end of a phone line billing by the month. Every practitioner in this country can be that person. Stop training them to doubt it.
References
1. Hansard, HC Deb, 11 September 2025, Non-Surgical Aesthetic and Cosmetic Treatments.
2. House of Commons Library (2025) Non-surgical cosmetic procedures: the case for regulation, CBP-10331.
3. Save Face (2023) Consumer Complaints Data.
4. Vascular Occlusion Following Dermal Filler Injections: A Systematic Review of Clinical Evidence and Emergency Management (2024) J. Vasc. Dis. (MDPI), 6(3), 51.